Vistin Pharma ASA
OSE:VISTN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Vistin Pharma ASA
Income from Continuing Operations
Vistin Pharma ASA
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Vistin Pharma ASA
OSE:VISTN
|
Income from Continuing Operations
kr74.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
|
Photocure ASA
OSE:PHO
|
Income from Continuing Operations
-kr1.5m
|
CAGR 3-Years
72%
|
CAGR 5-Years
42%
|
CAGR 10-Years
27%
|
|
|
N
|
Navamedic ASA
OSE:NAVA
|
Income from Continuing Operations
-kr23.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
|
S
|
SoftOx Solutions AS
OSE:SOFTX
|
Income from Continuing Operations
-kr15.5m
|
CAGR 3-Years
38%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
O
|
Oncoinvent ASA
OSE:ONCIN
|
Income from Continuing Operations
-kr107.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Vistin Pharma ASA
Glance View
Vistin Pharma ASA engages in the manufacture and sale of metformin products. The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The company was created as a result of spin-off of Weifa AS. The company specializes in manufacture of Active Pharmaceutical Ingredients (API) and Solid Dosage Forms. Its products portfolio is comprised of Metformin, Pholcodine and Codeine Phosphate, among others. The firm's products are sold domestically and abroad, including markets in Asia, America, Africa and Europe.
See Also
What is Vistin Pharma ASA's Income from Continuing Operations?
Income from Continuing Operations
74.8m
NOK
Based on the financial report for Dec 31, 2025, Vistin Pharma ASA's Income from Continuing Operations amounts to 74.8m NOK.
What is Vistin Pharma ASA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
15%
Over the last year, the Income from Continuing Operations growth was 19%.
